Loading stock data…
RNR
$282.74+0.63 (+0.22%)
After Hours$282.74+0.00 (+0.00%)· Last close Jun 9
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
RenaissanceRe Holdings Ltd. in the Financial Services sector is trading at $282.74. Wall Street consensus targets $326.80 (15 analysts), implying a +15.6% move over the next 12 months. The stock is currently 11% below its 52-week high of $318.20, remaining 2.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +15.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 31) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$282.74
Potential Downside
0%
Whystock Fair Value$282.74
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Hold
Mean target$326.80+15.6%
Range$277.00 – $431.00
Fundamentals
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.29%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.37%
Volume
Today's trading volume
296,324
Recent News
2 Reasons to Watch RNR and 1 to Stay Cautious
RenaissanceRe trades at $282.24 and has moved in lockstep with the market. Its shares have returned 7.1% over the last six months while the S&P 500 has gained 8%.
What RenaissanceRe Holdings (RNR)'s Capital Allocation Focus at Morgan Stanley Conference Means For Shareholders
RenaissanceRe Holdings recently presented at the Morgan Stanley US Financials Conference 2026 in New York, where management outlined its underwriting approach, investment income profile, and capital allocation priorities. The company’s emphasis on disciplined risk selection, portfolio optimization, and returning capital to shareholders offers a clearer picture of how it is balancing growth initiatives with balance sheet strength. Next, we’ll examine how this focus on disciplined underwriting...
Here's Why Investors Should Hold RenaissanceRe Stock for Now
RenaissanceRe's disciplined underwriting, strong cash flow and shareholder returns support its outlook, even as premium growth and leverage remain watchpoints.
Why Is RenaissanceRe (RNR) Down 4.6% Since Last Earnings Report?
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NMIH Stock Trading at a Discount to Industry at 1.08X: Time to Hold?
NMI Holdings remains poised to gain from higher new insurance written volume, a comprehensive reinsurance program and prudent capital deployment.